What is a stock summary page? Click here for an overview.
Business Description
Luyan Pharma Co Ltd
ISIN : CNE1000025W1
Share Class Description:
SZSE:002788: Class ACompare
Compare
Traded in other countries / regions
002788.China IPO Date
2016-02-18Description
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 1.59 | |||||
| Debt-to-EBITDA | 7.97 | |||||
| Interest Coverage | 3.3 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.34 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.2 | |||||
| 3-Year EBITDA Growth Rate | 3.6 | |||||
| 3-Year EPS without NRI Growth Rate | 6.3 | |||||
| 3-Year Book Growth Rate | 8.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.67 | |||||
| 9-Day RSI | 54.96 | |||||
| 14-Day RSI | 50.8 | |||||
| 3-1 Month Momentum % | 2.82 | |||||
| 6-1 Month Momentum % | -1.53 | |||||
| 12-1 Month Momentum % | -1.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 50.7 | |||||
| Days Sales Outstanding | 106.31 | |||||
| Days Payable | 70.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.72 | |||||
| Dividend Payout Ratio | 0.35 | |||||
| 3-Year Dividend Growth Rate | 14.5 | |||||
| Forward Dividend Yield % | 3.72 | |||||
| 5-Year Yield-on-Cost % | 11.17 | |||||
| Shareholder Yield % | 6.77 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7.36 | |||||
| Operating Margin % | 3.28 | |||||
| Net Margin % | 1.63 | |||||
| FCF Margin % | 1.45 | |||||
| ROE % | 10.68 | |||||
| ROA % | 2.7 | |||||
| ROIC % | 6.52 | |||||
| 3-Year ROIIC % | 6.76 | |||||
| ROC (Joel Greenblatt) % | 9.45 | |||||
| ROCE % | 16.16 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.52 | |||||
| PE Ratio without NRI | 9.52 | |||||
| Shiller PE Ratio | 11.47 | |||||
| Price-to-Owner-Earnings | 113.52 | |||||
| PEG Ratio | 1.44 | |||||
| PS Ratio | 0.15 | |||||
| PB Ratio | 0.97 | |||||
| Price-to-Tangible-Book | 1.21 | |||||
| Price-to-Free-Cash-Flow | 10.56 | |||||
| Price-to-Operating-Cash-Flow | 5.22 | |||||
| EV-to-EBIT | 12.16 | |||||
| EV-to-EBITDA | 12.16 | |||||
| EV-to-Revenue | 0.38 | |||||
| EV-to-FCF | 26.31 | |||||
| Price-to-GF-Value | 0.89 | |||||
| Price-to-Projected-FCF | 2.52 | |||||
| Price-to-DCF (Earnings Based) | 0.55 | |||||
| Price-to-DCF (FCF Based) | 0.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.88 | |||||
| Price-to-Graham-Number | 0.72 | |||||
| Price-to-Net-Current-Asset-Value | 7.13 | |||||
| Earnings Yield (Greenblatt) % | 8.22 | |||||
| FCF Yield % | 9.51 | |||||
| Forward Rate of Return (Yacktman) % | 4.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Luyan Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 20,508.841 | ||
| EPS (TTM) (Â¥) | 0.847 | ||
| Beta | 1.04 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.21 | ||
| Volatility % | 23.87 | ||
| 14-Day RSI | 50.8 | ||
| 14-Day ATR (Â¥) | 0.194547 | ||
| 20-Day SMA (Â¥) | 7.966 | ||
| 12-1 Month Momentum % | -1.53 | ||
| 52-Week Range (Â¥) | 6.88 - 9.56 | ||
| Shares Outstanding (Mil) | 388.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Luyan Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Luyan Pharma Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Luyan Pharma Co Ltd Frequently Asked Questions
What is Luyan Pharma Co Ltd(SZSE:002788)'s stock price today?
The current price of SZSE:002788 is ¥8.06. The 52 week high of SZSE:002788 is ¥9.56 and 52 week low is ¥6.88.
When is next earnings date of Luyan Pharma Co Ltd(SZSE:002788)?
The next earnings date of Luyan Pharma Co Ltd(SZSE:002788) is .
Does Luyan Pharma Co Ltd(SZSE:002788) pay dividends? If so, how much?
The Dividend Yield %  of Luyan Pharma Co Ltd(SZSE:002788) is 3.72% (As of Today), Highest Dividend Payout Ratio of Luyan Pharma Co Ltd(SZSE:002788) was 0.35. The lowest was 0.15. And the median was 0.21. The  Forward Dividend Yield % of Luyan Pharma Co Ltd(SZSE:002788) is 3.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers